[PDF][PDF] Pre-mRNA splicing: awash in a sea of proteins
What's in a spliceosome? More than we ever imagined, according to recent reports employing
proteomics techniques to analyze this multi-megadalton machine. As of 1999, around 100 …
proteomics techniques to analyze this multi-megadalton machine. As of 1999, around 100 …
From birth to death: the complex lives of eukaryotic mRNAs
MJ Moore - Science, 2005 - science.org
Recent work indicates that the posttranscriptional control of eukaryotic gene expression is
much more elaborate and extensive than previously thought, with essentially every step of …
much more elaborate and extensive than previously thought, with essentially every step of …
[HTML][HTML] Pre-mRNA processing reaches back totranscription and ahead to translation
MJ Moore, NJ Proudfoot - Cell, 2009 - cell.com
The pathway from gene activation in the nucleus to mRNA translation and decay at specific
locations in the cytoplasm is both streamlined and highly interconnected. This review …
locations in the cytoplasm is both streamlined and highly interconnected. This review …
[HTML][HTML] Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Spike (S) proteins of coronaviruses, including the coronavirus that causes severe acute
respiratory syndrome (SARS), associate with cellular receptors to mediate infection of their target …
respiratory syndrome (SARS), associate with cellular receptors to mediate infection of their target …
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
HA Burris 3rd, MJ Moore, J Andersen… - Journal of clinical …, 1997 - ascopubs.org
PURPOSE Most patients with advanced pancreas cancer experience pain and must limit
their daily activities because of tumor-related symptoms. To date, no treatment has had a …
their daily activities because of tumor-related symptoms. To date, no treatment has had a …
[PDF][PDF] Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of …
MJ Moore, D Goldstein, J Hamm, A Figer… - Journal of clinical …, 2007 - Citeseer
Purpose Patients with advanced pancreatic cancer have a poor prognosis and there have
been no improvements in survival since the introduction of gemcitabine in 1996. Pancreatic …
been no improvements in survival since the introduction of gemcitabine in 1996. Pancreatic …
[HTML][HTML] K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
…, L Shepherd, HJ Au, C Langer, MJ Moore… - … England Journal of …, 2008 - Mass Medical Soc
Background Treatment with cetuximab, a monoclonal antibody directed against the epidermal
growth factor receptor, improves overall and progression-free survival and preserves the …
growth factor receptor, improves overall and progression-free survival and preserves the …
[HTML][HTML] Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer
…, LS Rosen, L Fehrenbacher, MJ Moore… - … England Journal of …, 2000 - Mass Medical Soc
Background The combination of fluorouracil and leucovorin has until recently been standard
therapy for metastatic colorectal cancer. Irinotecan prolongs survival in patients with …
therapy for metastatic colorectal cancer. Irinotecan prolongs survival in patients with …
Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized …
…, JT Roberts, L Dogliotti, T Oliver, MJ Moore… - Journal of clinical …, 2000 - ascopubs.org
PURPOSE: Gemcitabine plus cisplatin (GC) and methotrexate, vinblastine, doxorubicin, and
cisplatin (MVAC) were compared in patients with locally advanced or metastatic transitional-…
cisplatin (MVAC) were compared in patients with locally advanced or metastatic transitional-…
[HTML][HTML] Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer
CM Ribic, DJ Sargent, MJ Moore… - … England Journal of …, 2003 - Mass Medical Soc
Background Colon cancers with high-frequency microsatellite instability have clinical and
pathological features that distinguish them from microsatellite-stable tumors. We investigated …
pathological features that distinguish them from microsatellite-stable tumors. We investigated …